Rome, Italy, 7 April 2025 - Angelini Ventures, the corporate venture firm of Angelini Industries focused on investing in ...

If Kennedy were to pursue a ban on TV drug ads, it’s improbable that it would withstand legal scrutiny and industry lobby ...

The owners of what was once Pennsylvania’s biggest coal-fired power plant said Wednesday that they will turn it into a $10 ...

Merck signed a licensing agreement for a heart disease drug with Jiangsu Hengrui Pharmaceuticals worth up to $2 billion. Clover Biopharmaceuticals said Gavi sent notice of the termination of their ...

Supported by Merck Sharp and Dohme, a subsidiary of Merck (Rahway, NJ). Disclosure forms provided by the authors are available with the full text of this article at NEJM.org. We thank the patients ...

Also, a Boston company won clearance for a trial to ... An interim analysis showed nemvaleukin in combination with Merck’s Keytruda did not achieve a statistically significant improvement ...

Merck was one of the pioneers of the cholesterol-lowering statins that launched in the 1980s and 1990s and changed medical practice. But it hasn’t been as successful with cholesterol medicines since ...

Last year, EMD Serono took a big step by moving its U.S. headquarters to Boston’s Seaport neighborhood. EMD Serono is the North American drug development business of Merck KGaA, Darmstadt ...

Bill Chisholm, cofounder of private equity firm STG, paid $6.1 billion for the Boston Celtics. Chisholm is a lifelong Celtics fan from Massachusetts. The sale was the largest ever for a North ...

A consortium that includes tech and real estate investors, alongside a private equity firm, has reached a deal to buy the National Basketball Association’s Boston Celtics for $6.1 billion.

March 20 (UPI) --Symphony Technology Group managing partner Bill Chisholm agreed to buy the NBA's Boston Celtics for $6.1 billion, he announced Thursday. The sale will set a record for the highest ...